Latest News-Porda Havas International Financial Communications Group Mediaroom_Page

Recbio and Rhegen Signed an mRNA Vaccine Cooperation Agreement

TAIZHOU, China, Sept. 29, 2021 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (referred to as ...

2021-09-29 19:37 2306

HeartCare Medical Announces 2021 Interim Results

HONG KONG, Aug. 31, 2021 /PRNewswire/ -- Shanghai HeartCare Medical Technology Corporation Limited ...

2021-08-31 13:11 3042

Viva Biotech Announced 2021 Interim Results

Revenue Increased by 419.5% YoY, CRO Business Income Increased by 62.5% YoY, O rderBacklog Recorded ...

2021-08-31 01:32 4791

Ocumension Acquires all the Equity Interests in Two Ophthalmic Products Mainland China, Further Enhancing its Pipeline Strength

HONG KONG, Aug. 25, 2021 /PRNewswire/ -- Beijing time, August 24, 2021, Ocumension Therapeutics ann...

2021-08-25 12:35 2813

China Medical System Holdings Limited 2021 Interim Results Announcement

Business Performance Reached Record High Turnover Increased by 23.6% to RMB3,843.0 Million Profit In...

2021-08-24 10:52 3318

Ocumension Therapeutics Announces 2021 Interim Results

Company loss narrowed sharply by 96% Business Income Increased By More Than 26 Times Year-on-Year ...

2021-08-21 00:19 16404

MediTrust Health Raises Over RMB2 Billion in Series C Financing Successfully: ESG Drives Value Creation

HONG KONG, Aug. 18, 2021 /PRNewswire/ -- Shanghai MediTrust Health Technology Co., Ltd. (hereinafte...

2021-08-18 20:14 1478

MediTrust Health Raises Over RMB2 Billion in Series C Financing Successfully: ESG Drives Value Creation

HONG KONG, Aug. 17, 2021 /PRNewswire/ -- Shanghai MediTrust Health Technology Co., Ltd. (hereinafte...

2021-08-17 19:47 1443

Sihuan Pharmaceutical (0460.HK): Say "No" to Smuggled Products - Advocate 'Positive Energy' of China's Medical Aesthetics Industry

HONG KONG, Aug. 11, 2021 /PRNewswire/ -- On June 10, 2021, the National Health Commission, leading ...

2021-08-11 17:59 3340

Coller Capital And Ping An Overseas Holdings Announce Closure Of One Of The World's Largest Private Credit Secondaries Transaction

HONG KONG and SHANGHAI, Aug. 3, 2021 /PRNewswire/ -- Coller Capital ("Coller") and Ping An Overseas...

2021-08-03 16:05 3614

Coller Capital And Ping An Overseas Holdings Announce Closure Of One Of The World's Largest Private Credit Secondaries Transaction

HONG KONG and SHANGHAI, Aug. 3, 2021 /PRNewswire/ -- Coller Capital ("Coller") and Ping An Overseas...

2021-08-03 16:05 3954

PAAMC HK's Flagship Fund Awarded ESG Fixed Income Fund of the Year (Asia) by Environmental Finance

HONG KONG, June 29, 2021 /PRNewswire/ -- Ping An of China Asset Management ( Hong Kong) Company Limi...

2021-06-29 18:17 1107

Totient, a Viva Biotech Portfolio Company, has been Acquired by AbSci

SHANGHAI, June 15, 2021 /PRNewswire/ -- Viva Biotech (01873.HK) declared today that Totient, one of...

2021-06-16 10:14 22331

Sihuan Pharmaceutical (0460.HK) Obtained the Exclusive Distribution Right for LipiVage(R) Fat Collection System in Greater China and South Korea

HONG KONG, June 4, 2021 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (the "Company" or...

2021-06-04 14:03 8917

Two Products of Zhaoke Ophthalmology (6622.HK) Passed The On-Site Inspection for Drug Registration of The National Medical Products Administration and The GMP Compliance Inspection of The Guangdong Medical Products Administration

HONG KONG, May 24, 2021 /PRNewswire/ -- Zhaoke Ophthalmology Limited ("Zhaoke Ophthalmology" or t...

2021-05-24 16:58 5058

Viva Biotech and BioMap Reached a Strategic Collaboration Agreement, To Jointly Accelerate the Early Drug Discovery through AI Technology

SHANGHAI, May 10, 2021 /PRNewswire/ -- Hosted by BioMap and Adock, the first generation of China Bi...

2021-05-10 18:21 2248

Viva Biotech Announced 2020 Annual Results

The Group's Revenue Surged by 115.7% YoY Revenue from the CFS Business Increased Significantly by ...

2021-03-31 07:03 3160

Hang Seng Ping An Asian Income Fund Offers Investors Chance to Capture Long-term Growth in Asian Market

HONG KONG, March 29, 2021 /PRNewswire/ -- The Hang Seng Ping An Asian Income Fund# (the 'Fund') ope...

2021-03-29 18:12 1685

Ocumension Therapeutics (1477.HK) Reports Revenue Growth in 2020, National Commercial Construction has been started to become outstanding

HONG KONG, March 20, 2021 /PRNewswire/ -- The Chinese ophthalmology platform company,Ocumension The...

2021-03-20 18:20 8473

Sihuan Pharmaceutical (0460.HK): 'A Friend of Time' 2021 - The Turning-point Year

HONG KONG, March 16, 2021 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. plays a pivotal...

2021-03-16 14:48 3254